These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging. Menderes G; Azodi M; Schwartz P; Silasi DA Int J Gynecol Cancer; 2015 Jan; 25(1):160-5. PubMed ID: 25386859 [TBL] [Abstract][Full Text] [Related]
23. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa]. Bolze PA; Collinet P; Golfier F; Bourgin C Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727 [TBL] [Abstract][Full Text] [Related]
25. [Laparoscopic para-aortic and pelvic lymph node excision--initial experiences and development of a technique]. Schneider A; Krause N; Kühne-Heid R; Kamprath S; Endisch U; Merker A; Nöschel H Zentralbl Gynakol; 1996; 118(9):498-504. PubMed ID: 8992817 [TBL] [Abstract][Full Text] [Related]
26. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study. Kikuchi A; Yanase T; Sasagawa M; Honma S J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer. Yokoyama Y; Sakamoto T; Sato S; Saito Y Eur J Gynaecol Oncol; 1999; 20(5-6):361-6. PubMed ID: 10609495 [TBL] [Abstract][Full Text] [Related]
28. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma. Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132 [TBL] [Abstract][Full Text] [Related]
29. Lymph node metastasis and retroperitoneal lymphadenectomy in ovarian cancer. Wu PC; Lang JH; Huang RL; Qu JY; Wang H; Tang MY; Zhao RG; Lian LJ Baillieres Clin Obstet Gynaecol; 1989 Mar; 3(1):143-55. PubMed ID: 2661088 [TBL] [Abstract][Full Text] [Related]
30. Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease? Naik R; Nordin A; Cross PA; Hemming D; de Barros Lopes A; Monaghan JM Gynecol Oncol; 2000 Aug; 78(2):176-80. PubMed ID: 10926799 [TBL] [Abstract][Full Text] [Related]
31. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network. Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880 [TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Spirtos NM; Gross GM; Freddo JL; Ballon SC Gynecol Oncol; 1995 Mar; 56(3):345-52. PubMed ID: 7705667 [TBL] [Abstract][Full Text] [Related]
34. Early ovarian cancer surgery with indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, pelvic part). Kimmig R; Buderath P; Rusch P; Mach P; Aktas B J Gynecol Oncol; 2017 Sep; 28(5):e68. PubMed ID: 28657229 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma. Ho CM; Chien TY; Shih BY; Huang SH Gynecol Oncol; 2003 Mar; 88(3):394-9. PubMed ID: 12648592 [TBL] [Abstract][Full Text] [Related]
37. Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer. Vergote I; Amant F; Berteloot P; Van Gramberen M Int J Gynecol Cancer; 2002; 12(1):22-6. PubMed ID: 11860532 [TBL] [Abstract][Full Text] [Related]
38. Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy. Aletti GD; Powless C; Bakkum-Gamez J; Wilson TO; Podratz KC; Cliby WA Gynecol Oncol; 2009 Jul; 114(1):32-6. PubMed ID: 19361840 [TBL] [Abstract][Full Text] [Related]
39. Maximum effort in the management of ovarian cancer, including pelvic and para-aortic lymphadenectomy. Allen DG; Planner RS; Grant PT Aust N Z J Obstet Gynaecol; 1992 Feb; 32(1):50-3. PubMed ID: 1586336 [TBL] [Abstract][Full Text] [Related]
40. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination. Altay A; Toptas T; Dogan S; Simsek T; Pestereli E Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]